liver
LIVER OVERVIEW
Liver Functions
Metabolism: The liver plays a central role in the metabolic processes of carbohydrates, fats, and proteins.
Detoxification: It helps in breaking down harmful substances, including drugs and alcohol, and eliminates toxins from the bloodstream.
Protein Production: The liver produces essential proteins such as albumin (regulates osmotic pressure and carries hormones) and clotting factors (for blood coagulation).
Bile Production: The liver produces bile, which is important for the digestion and absorption of fats and fat-soluble vitamins.
Liver Function Tests (LFTs)
Elevated values indicate potential liver damage and dysfunction, including:
AST (aspartate aminotransferase): An enzyme predominantly found in the liver; elevated levels indicate liver cell injury.
ALT (alanine aminotransferase): An enzyme more specific to the liver; significant elevations often indicate liver impaction.
Bilirubin: A byproduct of the breakdown of red blood cells; increased levels can indicate a blockage or liver dysfunction.
Albumin: Decreased levels may reflect liver synthetic dysfunction or chronic liver disease.
PT (Prothrombin Time): Increased PT indicates impaired clotting capability, commonly due to liver dysfunction.
HEPATITIS
Definition: Inflammation of the liver characterized by liver cell injury.
Causes:
Viral Infections: Including Hepatitis A (HAV), B (HBV), C (HCV), D (HDV), and E (HEV).
Alcohol (ETOH) Consumption: Chronic alcohol use leads to liver inflammation and damage.
Medications/Chemicals: Certain medications or toxins can lead to liver inflammation.
Autoimmune Disorders: Conditions where the body's immune system attacks liver cells.
Metabolic Disorders: Genetic conditions causing abnormal liver metabolism.
Types:
Acute Hepatitis: Lasts for 1–6 months and is potentially reversible.
Chronic Hepatitis: Persistent liver inflammation leading to fibrosis, cirrhosis, and potential liver failure.
HEPATITIS TYPES
Hepatitis A (HAV)
Transmission: Fecal-oral route primarily through contaminated food or water.
Risk Factors: Common in areas with poor sanitation, associated with large gatherings, and travel to endemic regions.
Clinical Course: Often presents with flu-like symptoms; self-limiting course.
Prevention: Available vaccine, hand hygiene, and post-exposure immune globulin administration.
Hepatitis B (HBV)
Transmission: Primarily through blood and bodily fluids; can survive outside the body for 7 days.
Risk Factors: Intravenous drug use, unprotected sexual contact, healthcare workers, and dialysis patients.
Clinical Course: Can present acutely and has a potential to become chronic (4–6 months infectious).
Prevention: Vaccination (3 doses), condom use, and avoidance of needle sharing.
Hepatitis C (HCV)
Transmission: Primarily through blood exposure.
Key Points: Often asymptomatic in initial stages; it is the leading cause of chronic liver disease.
Prevention: No vaccine; screening of high-risk individuals is crucial.
Hepatitis D (HDV)
Definition: An incomplete virus that requires Hepatitis B for replication.
Clinical Implications: Can exacerbate liver disease in patients chronically infected with HBV.
Hepatitis E (HEV)
Transmission: Primarily through the fecal-oral route and often associated with contaminated water supplies.
Seen in: Developing countries with inadequate sanitation.
ACUTE HEPATITIS
Clinical Manifestations:
Symptoms include flu-like manifestations such as fever, nausea/vomiting (N/V), fatigue, right upper quadrant (RUQ) pain, jaundice, pruritus (itching), and elevated liver function tests (LFTs).
Management:
Focused on supportive care, including rest and nutrition (low-fat diet), with strict avoidance of alcohol.
CHRONIC HEPATITIS
Pathophysiology: Involves hepatocyte destruction leading to fibrosis, progressing to cirrhosis and potentially liver failure.
Risk Factors: Chronic alcohol use, obesity, diabetes, and immunocompromised state.
Clinical Manifestations:
Symptoms include anemia, coagulation problems, spider angiomas, palmar erythema, ascites, and hepatic encephalopathy.
Treatment:
Hepatitis B Treatment: Nucleoside/nucleotide analogs and interferon therapy.
Hepatitis C Treatment: Direct-acting antivirals (DAAs) are standard.
Nursing Care: Includes monitoring lab values, ensuring proper nutrition, managing pruritus, providing rest, and educating patients about the disease.
CIRRHOSIS
Pathophysiology: A chronic condition characterized by severe liver damage resulting from ongoing fibrosis leading to a loss of liver function.
Clinical Manifestations: Symptoms include jaundice, ascites, peripheral edema, spider angiomas, palmar erythema, anemia, and coagulation problems.
Diagnostics: Elevated liver function tests (LFTs), increased bilirubin, decreased albumin, increased prothrombin time (PT), and a liver biopsy being the definitive diagnostic tool.
COMPLICATIONS OF CIRRHOSIS
Portal Hypertension: Results in complications such as varices and ascites.
Leads to significant psychosocial and physical issues, particularly in managing complications like variceal hemorrhaging.
Ascites Management: Includes sodium restriction, diuretics, albumin infusion, and paracentesis to relieve fluid buildup.
Varices:
Prevention: Includes avoiding alcohol and NSAIDs and using beta-blockers.
Management of Active Bleeding: Requires IV access, use of octreotide, and endoscopic procedures like ligation or sclerotherapy.
Emergency Measures: Balloon tamponade can be employed in acute situations, necessitating careful nursing care and readiness for airway emergencies.
HEPATIC ENCEPHALOPATHY
Cause: Results from increased ammonia levels due to liver dysfunction.
Signs: Early signs include confusion and asterixis (tremor of the wrist).
Treatment: Lactulose is administered to reduce ammonia levels; prevention of constipation is critical.
ACUTE LIVER FAILURE
Key Points: Rapid onset of symptoms, often with no prior liver disease, with acetaminophen overdose being the most common cause.
Signs: Includes early cognitive changes and progressive encephalopathy, potentially leading to renal failure.
Treatment: Liver transplant is often the only effective treatment.
LIVER CANCER
Causes: Often stemming from Hepatitis C infection and cirrhosis conditions.
Signs: Symptoms mirror those of cirrhosis, leading to challenges in diagnosis.
Diagnosis: Imaging techniques such as CT or MRI, with no biopsy indicated to avoid causing additional complications.
Treatment: Options include surgical resection, although prognoses are generally poor due to late-stage diagnoses.
LIVER TRANSPLANTATION
Processes: Can involve live or cadaver donors; requirements include strict lifelong immunosuppression and monitoring for recurrence of Hepatitis B or C.
PANCREAS
ACUTE PANCREATITIS
Pathophysiology: Characterized by premature activation of pancreatic enzymes resulting in autodigestion.
Causes: Major causes include alcohol, gallstones (referred to as the “4 F’s”: female, fat, forty, fertile), and high triglycerides.
Clinical Manifestations: Symptoms primarily include left upper quadrant (LUQ) pain, decreased bowel sounds, elevated amylase/lipase, and signs such as Cullen’s sign (bruising around umbilicus) and Grey Turner’s sign (flank bruising).
Complications: Can include respiratory complications, clotting, hypocalcemia, shock, and the formation of pseudocysts.
Management: Treatment focuses on pain control, IV fluids, NPO status, and NG tube insertion when necessary, alongside the administration of oxygen and proton pump inhibitors.
CHRONIC PANCREATITIS
Clinical Manifestations: Presents with recurrent pain, weight loss, steatorrhea (fatty stools), and potential onset of diabetes.
Treatment Strategy: Involves a low-fat diet, avoidance of alcohol/smoking, enzyme replacement therapy, and management of diabetes as necessary.
PANCREATIC CANCER
Risk Factors: Include significant associations with smoking, chronic pancreatitis history, diabetes, and high-fat diets.
Clinical Manifestations: Characterized by pain, weight loss, jaundice, and general malaise (cachexia).
Diagnosis and Treatment: Diagnosis relies on imaging techniques like CT; major interventions may involve Whipple procedure with nursing care similar to that of pancreatitis, focusing on multidisciplinary support and nutritional needs.
ULTRA HIGH-YIELD SUMMARY
Hepatitis:
A = Fecal-oral transmission.
B = Bloodborne transmission (vaccine available).
C = Chronic and leading cause of liver disease (no vaccine).
Cirrhosis: Think liver failure and associated complications; including ascites, varices, and hepatic encephalopathy.
Pancreatitis: Characterized by significant LUQ pain and elevated amylase/lipase levels; management includes NPO status and IV fluids.
Varices: High risk for bleeding constitutes a medical emergency; immediate management is critical.
Hepatic Encephalopathy: Elevated ammonia levels lead to confusion, requiring management with lactulose.